BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND KEAP1, INrf2, ENSG00000079999, 9817, Q14145, MGC9454, MGC4407, MGC20887, MGC1114, MGC10630, KLHL19, KIAA0132
43 results:

  • 1. Dual-layer spectral detector CT: A noninvasive preoperative tool for predicting histopathological differentiation in pancreatic ductal adenocarcinoma.
    Liu W; Xie T; Chen L; Tang W; Zhang Z; Wang Y; Deng W; Xie X; Zhou Z
    Eur J Radiol; 2024 Apr; 173():111327. PubMed ID: 38330535
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. CPT1B maintains redox homeostasis and inhibits ferroptosis to induce gemcitabine resistance via the keap1/NRF2 axis in pancreatic cancer.
    Tuerhong A; Xu J; Wang W; Shi S; Meng Q; Hua J; Liu J; Zhang B; Yu X; Liang C
    Surgery; 2024 May; 175(5):1264-1275. PubMed ID: 38302326
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Metabolic Reprogramming via ACOD1 depletion enhances function of human induced pluripotent stem cell-derived CAR-macrophages in solid tumors.
    Wang X; Su S; Zhu Y; Cheng X; Cheng C; Chen L; Lei A; Zhang L; Xu Y; Ye D; Zhang Y; Li W; Zhang J
    Nat Commun; 2023 Sep; 14(1):5778. PubMed ID: 37723178
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Isoliquiritigenin induces HMOX1 and GPX4-mediated ferroptosis in gallbladder cancer cells.
    Wang Z; Li W; Wang X; Zhu Q; Liu L; Qiu S; Zou L; Liu K; Li G; Miao H; Yang Y; Jiang C; Liu Y; Shao R; Wang X; Liu Y
    Chin Med J (Engl); 2023 Sep; 136(18):2210-2220. PubMed ID: 37488674
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Immunotoxicity induced by triclocarban exposure in zebrafish triggering the risk of pancreatic cancer.
    Wang H; Li X; Wang W; Xu J; Ai W; Huang H; Wang X
    Environ Pollut; 2023 May; 325():121458. PubMed ID: 36934961
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. UBR7 inhibits HCC tumorigenesis by targeting keap1/Nrf2/Bach1/HK2 and glycolysis.
    Zhao L; Kang M; Liu X; Wang Z; Wang Y; Chen H; Liu W; Liu S; Li B; Li C; Chang A; Tang B
    J Exp Clin Cancer Res; 2022 Nov; 41(1):330. PubMed ID: 36419136
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinical application of comprehensive genomic profiling panel to thoracic malignancies: A single-center retrospective study.
    Kunimasa K; Sugimoto N; Kawamura T; Yamasaki T; Honma K; Nagata S; Kukita Y; Fujisawa F; Inoue T; Yamaguchi Y; Kitasaka M; Wakamatsu T; Yamai T; Yamamoto S; Hayashi T; Inoue T; Tamiya M; Imamura F; Nishimura K; Nishino K
    Thorac Cancer; 2022 Nov; 13(21):2970-2977. PubMed ID: 36100256
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Integrating network pharmacology and experimental models to investigate the efficacy of QYHJ on pancreatic cancer.
    Yang PW; Xu PL; Cheng CS; Jiao JY; Wu Y; Dong S; Xie J; Zhu XY
    J Ethnopharmacol; 2022 Oct; 297():115516. PubMed ID: 35817247
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. GSTM3 deficiency impedes DNA mismatch repair to promote gastric tumorigenesis via CAND1/NRF2-keap1 signaling.
    Chen T; Jinlin D; Wang F; Yuan Z; Xue J; Lu T; Huang W; Liu Y; Zhang Y
    Cancer Lett; 2022 Jul; 538():215692. PubMed ID: 35487311
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Mitochondrial Calcium Uniporter Drives Metastasis and Confers a Targetable Cystine Dependency in pancreatic cancer.
    Wang X; Li Y; Li Z; Lin S; Wang H; Sun J; Lan C; Wu L; Sun D; Huang C; Singh PK; Hempel N; Trebak M; DeNicola GM; Hao J; Yang S
    Cancer Res; 2022 Jun; 82(12):2254-2268. PubMed ID: 35413105
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. CRISPR-Cas9-based genome-wide screening identified novel targets for treating sorafenib-resistant hepatocellular carcinoma: a cross-talk between FGF21 and the NRF2 pathway.
    Chen J; Jiang S; Shao H; Li B; Ji T; Staiculescu D; He J; Zhao J; Cai L; Liang X; Xu J; Cai X
    Sci China Life Sci; 2022 Oct; 65(10):1998-2016. PubMed ID: 35380342
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Landscape of
    Salem ME; El-Refai SM; Sha W; Puccini A; Grothey A; George TJ; Hwang JJ; O'Neil B; Barrett AS; Kadakia KC; Musselwhite LW; Raghavan D; Van Cutsem E; Tabernero J; Tie J
    JCO Precis Oncol; 2022 Mar; 6():e2100245. PubMed ID: 35319967
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Determining oncogenic patterns and cancer predisposition through the transcriptomic profile in Mitchell-Riley syndrome with heterotopic gastric mucosa and duodenal atresia: a case report.
    Calcaterra V; Chiricosta L; Mazzon E; Gugnandolo A; Alberti D; Maestri L; Meroni M; Vestri E; Verduci E; Dilillo D; Zuccotti G; Pelizzo G
    Orphanet J Rare Dis; 2021 Oct; 16(1):455. PubMed ID: 34715892
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Nrf2 Activation Sensitizes K-Ras Mutant pancreatic cancer Cells to Glutaminase Inhibition.
    Hamada S; Matsumoto R; Tanaka Y; Taguchi K; Yamamoto M; Masamune A
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672789
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Physical plasma-derived oxidants sensitize pancreatic cancer cells to ferroptotic cell death.
    Kumar N; Perez-Novo C; Shaw P; Logie E; Privat-Maldonado A; Dewilde S; Smits E; Berghe WV; Bogaerts A
    Free Radic Biol Med; 2021 Apr; 166():187-200. PubMed ID: 33636332
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. ATDC binds to keap1 to drive NRF2-mediated tumorigenesis and chemoresistance in pancreatic cancer.
    Purohit V; Wang L; Yang H; Li J; Ney GM; Gumkowski ER; Vaidya AJ; Wang A; Bhardwaj A; Zhao E; Dolgalev I; Zamperone A; Abel EV; Magliano MPD; Crawford HC; Diolaiti D; Papagiannakopoulos TY; Lyssiotis CA; Simeone DM
    Genes Dev; 2021 Feb; 35(3-4):218-233. PubMed ID: 33446568
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Overcoming hypoxia-induced resistance of pancreatic and lung tumor cells by disrupting the PERK-NRF2-HIF-axis.
    Küper A; Baumann J; Göpelt K; Baumann M; Sänger C; Metzen E; Kranz P; Brockmeier U
    Cell Death Dis; 2021 Jan; 12(1):82. PubMed ID: 33441543
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Magnetic Resonance Imaging May Be Able to Identify the Origin of Neuroendocrine Tumor Liver Metastases.
    Barat M; Soyer P; Al Sharhan F; Terris B; Oudjit A; Gaujoux S; Coriat R; Hoeffel C; Dohan A
    Neuroendocrinology; 2021; 111(11):1099-1110. PubMed ID: 33190136
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The p.Ser64Leu and p.Pro104Leu missense variants of PALB2 identified in familial pancreatic cancer patients compromise the DNA damage response.
    Zhang Y; Park JY; Zhang F; Olson SH; Orlow I; Li Y; Kurtz RC; Ladanyi M; Chen J; Toland AE; Zhang L; Andreassen PR
    Hum Mutat; 2021 Feb; 42(2):150-163. PubMed ID: 33169439
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Integrated genomic analysis reveals mutated ELF3 as a potential gallbladder cancer vaccine candidate.
    Pandey A; Stawiski EW; Durinck S; Gowda H; Goldstein LD; Barbhuiya MA; Schröder MS; Sreenivasamurthy SK; Kim SW; Phalke S; Suryamohan K; Lee K; Chakraborty P; Kode V; Shi X; Chatterjee A; Datta K; Khan AA; Subbannayya T; Wang J; Chaudhuri S; Gupta S; Shrivastav BR; Jaiswal BS; Poojary SS; Bhunia S; Garcia P; Bizama C; Rosa L; Kwon W; Kim H; Han Y; Yadav TD; Ramprasad VL; Chaudhuri A; Modrusan Z; Roa JC; Tiwari PK; Jang JY; Seshagiri S
    Nat Commun; 2020 Aug; 11(1):4225. PubMed ID: 32839463
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.